A Trial Testing Early vs Late Onset of EPO Alfa Treatment in Lower Risk MDS
Clinical trial NCT03223961 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03223961
- Sponsor
- Groupe Francophone des Myelodysplasies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-26
- Primary completion
- 2023-09-21
- Enrollment
- 124
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.